Allergy Asthma Immunol Res.  2014 May;6(3):252-256. 10.4168/aair.2014.6.3.252.

p53 Codon 72 Genetic Polymorphism in Asthmatic Children: Evidence of Interaction With Acid Phosphatase Locus 1

• Saccucci P
• Verrotti A
• Giannini C
• Verini M
• Chiarelli
• Neri A
• Magrini A

• KMID: 2260688
• DOI: http://doi.org/10.4168/aair.2014.6.3.252

Abstract

Several lines of evidence are implicating an increased persistence of apoptotic cells in patients with asthma. This is largely due to a combination of inhibition, or defects in the apoptotic process and/or impaired apoptotic cell removal mechanisms. Among apoptosis-inducing genes, an important role is played by p53. In the present study, we have investigated the possible relationship between p53 codon 72 polymorphism and asthma and the interaction with ACP1, a genetic polymorphism involved in the susceptibility to allergic asthma. We studied 125 asthmatic children and 123 healthy subjects from the Caucasian population of Central Italy. p53 codon 72 and ACP1 polymorphisms were evaluated using a restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) method. There is a statistically significant association between p53 codon 72 polymorphism and allergic asthma: Arg/Arg genotype is more represented in asthmatic patients than in controls (P=0.018). This association, however, is present in subjects with low ACP1 activity A/A and A/B only (P=0.023). The proportion of children with A/A and A/B genotype carrying Arg/Arg genotype is significantly high in asthmatic children than in controls (OR=1.941, 95% C.I. 1.042-3.628). Our finding could have important clinical implications since the subjects with A/A and A/B genotypes of ACP1 carrying Arg/Arg genotype are more susceptible to allergic asthma than Pro/Pro genotype.

Keyword

p53; ACP1; genetic polymorphism; asthma; allergy; apoptosis

MeSH Terms

Acid Phosphatase*
Apoptosis
Asthma
Child*
Codon*
Genotype
Humans
Hypersensitivity
Italy
Polymorphism, Genetic*
Acid Phosphatase
Codon

Reference

1. Brutsche MH, Brutsche IC, Wood P, Brass A, Morrison N, Rattay M, Mogulkoc N, Simler N, Craven M, Custovic A, Egan JJ, Woodcock A. Apoptosis signals in atopy and asthma measured with cDNA arrays. Clin Exp Immunol. 2001; 123:181–187.

2. Vignola AM, Chanez P, Chiappara G, Siena L, Merendino A, Reina C, Gagliardo R, Profita M, Bousquet J, Bonsignore G. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol. 1999; 103:563–573.

3. Walsh GM. Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins? Trends Pharmacol Sci. 2008; 29:6–11.

4. Trautmann A, Schmid-Grendelmeier P, Krüger K, Crameri R, Akdis M, Akkaya A, Bröcker EB, Blaser K, Akdis CA. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol. 2002; 109:329–337.

5. Trautmann A, Kruger K, Akdis M, Muller-Wening D, Akkaya A, Brocker EB, Blaser K, Akdis CA. Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int Arch Allergy Immunol. 2005; 138:142–150.

6. Benayoun L, Letuve S, Druilhe A, Boczkowski J, Dombret MC, Mechighel P, Megret J, Leseche G, Aubier M, Pretolani M. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med. 2001; 164:1487–1494.

7. Comhair SA, Xu W, Ghosh S, Thunnissen FB, Almasan A, Calhoun WJ, Janocha AJ, Zheng L, Hazen SL, Erzurum SC. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol. 2005; 166:663–674.

8. Zhou C, Yin G, Liu J, Liu X, Zhao S. Epithelial apoptosis and loss in airways of children with asthma. J Asthma. 2011; 48:358–365.

9. Lane DP. Cancer. p53, guardian of the genome. Nature. 1992; 358:15–16.

10. Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003; 33:357–365.

11. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer. 2004; 108:196–199.

12. Bottini N, Bottini E, Gloria-Bottini F, Mustelin T. Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. Arch Immunol Ther Exp (Warsz). 2002; 50:95–104.

13. Bottini N, Stefanini L, Williams S, Alonso A, Jascur T, Abraham RT, Couture C, Mustelin T. Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem. 2002; 277:24220–24224.

14. Bottini N, Ammendola M, Gloria-Bottini F. ACP1 is associated with allergy. Allergy. 2002; 57:651–652.

15. Bottini N, Otsu A, Borgiani P, Saccucci P, Stefanini L, Greco E, Fontana L, Hopkins JM, Mao XQ. Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. Clin Genet. 2003; 63:228–231.

16. Liu YG, Wu CG, Saccucci P, Gloria-Bottini F. ACP1 genotype and asthma in the Chinese Han population. Int Arch Allergy Immunol. 2005; 137:263–264.

17. Bottini E, Bergamaschi A, Magrini A, Spina C, Ammendola L, Grassi S, Bottini N, Gloria-Bottini F. Allergy and ACP1 genetic polymorphism. Allergy Asthma Proc. 2007; 28:87–92.

18. de la Calle-Martín O, Fabregat V, Romero M, Soler J, Vives J, Yagüe J. AccII polymorphism of the p53 gene. Nucleic Acids Res. 1990; 18:4963.

19. Lazaruk KD, Dissing J, Sensabaugh GF. Exon structure at the human ACP1 locus supports alternative splicing model for f and s isozyme generation. Biochem Biophys Res Commun. 1993; 196:440–446.

20. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. 2001; 344:350–362.

21. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet. 2002; 360:1313–1322.

22. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, Bonsignore G. Airway remodeling in asthma. Chest. 2003; 123:417S–422S.

23. James A. Airway remodeling in asthma. Curr Opin Pulm Med. 2005; 11:1–6.

24. Hackett TL, Knight DA. The role of epithelial injury and repair in the origins of asthma. Curr Opin Allergy Clin Immunol. 2007; 7:63–68.

25. Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int. 2008; 57:1–10.

26. Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Panizzolo C, Zanin ME, Zuin R, Maestrelli P, Fabbri LM, Saetta M. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med. 2006; 174:975–981.

27. Uller L, Persson CG, Erjefält JS. Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both? Trends Pharmacol Sci. 2006; 27:461–466.

28. Krysko DV, D'Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis. 2006; 11:1709–1726.

29. Lee SH, Park JS, Park CS. The search for genetic variants and epigenetics related to asthma. Allergy Asthma Immunol Res. 2011; 3:236–244.

30. Zheng SJ, Lamhamedi-Cherradi SE, Wang P, Xu L, Chen YH. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes. 2005; 54:1423–1428.

31. Jailwala P, Waukau J, Glisic S, Jana S, Ehlenbach S, Hessner M, Alemzadeh R, Matsuyama S, Laud P, Wang X, Ghosh S. Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. PLoS One. 2009; 4:e6527.